HC Wainwright & Co. maintains ESSA Pharma [EPIX] at Buy rating with a $17 price target
HC Wainwright & Co. maintained its ESSA Pharma [EPIX] rating to the equivalent of Buy but changed the price target to $17.0 from $10, in a research note dated 2021-01-11. That figure represents around a 41.43% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with Oppenheimer’s analysts […]
